Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Valeant to Increase Hospital Discounts For Two Heart Drugs

      Valeant to Increase Hospital Discounts For Two Heart Drugs

      savita thakur thakur17 May 2016 2:29 PM IST
      Valeant Pharmaceuticals International Inc said on Monday it would raise the discounts to hospitals on its heart drugs Nitropress and Isuprel to as...
      Starpharma, Ansell to sell Anti-Zika Condoms For Olympics

      Starpharma, Ansell to sell Anti-Zika Condoms For Olympics

      savita thakur thakur17 May 2016 2:25 PM IST
      Australian pharmaceutical company Starpharma Holdings Ltd said it is teaming up with world No. 2 condom maker Ansell Ltd to supply Zika virus-proof...
      USFDA  nod to Aurobindo Pharma

      USFDA nod to Aurobindo Pharma's anesthetic injection Bupivacaine Hydrochloride

      savita thakur thakur17 May 2016 1:24 PM IST
      New Delhi : Aurobindo Pharma has received final nod from the US health regulator to manufacture and market its anaesthetic Bupivacaine Hydrochloride...
      Sanofi Genzyme announces Multiple Sclerosis Collaboration with  Johns Hopkins School of Medicine

      Sanofi Genzyme announces Multiple Sclerosis Collaboration with Johns Hopkins School of Medicine

      savita thakur thakur17 May 2016 1:19 PM IST
      Cambridge : Sanofi Genzyme, the specialty care global business unit of Sanofi, announced a research collaboration with the Johns Hopkins School of...
      Linde India sets new standard in Oxygen Therapy with LIV™

      Linde India sets new standard in Oxygen Therapy with LIV™

      savita thakur thakur17 May 2016 9:09 AM IST
      Hyderabad : Linde India, a member of The Linde Group, launched LIV™ a new package for medical oxygen in a light-weight oxygen aluminium cylinder with...
      India And WHO Sign Agreement to Promote Traditional Medicine

      India And WHO Sign Agreement to Promote Traditional Medicine

      savita thakur thakur16 May 2016 3:15 PM IST
      New Delhi : India and the World Health Organisation (WHO) have signed an agreement for cooperation on promoting quality, safety and effectiveness of...
      Sanofi poses an ouster to Board Directors, if Medivation declines acquisition deal talks

      Sanofi poses an ouster to Board Directors, if Medivation declines acquisition deal talks

      savita thakur thakur16 May 2016 3:15 PM IST
      France's Sanofi SA was moving ahead on Friday with preparations to replace Medivation Inc's board of directors after the U.S. cancer drug maker...
      Bayer Terminates Phase II Study with Riociguat in Patients with Pulmonary Hypertension Associated with Idiopathic Interstitial Pneumonias

      Bayer Terminates Phase II Study with Riociguat in Patients with Pulmonary Hypertension Associated with Idiopathic Interstitial Pneumonias

      savita thakur thakur16 May 2016 9:20 AM IST
      Whippany : Following the recommendation of an independent Data Monitoring Committee (DMC), Bayer is terminating its Phase II study investigating...
      Four Pfizer brands to be acquired by Piramal Enterprises for Rs 110 cr

      Four Pfizer brands to be acquired by Piramal Enterprises for Rs 110 cr

      savita thakur thakur15 May 2016 4:12 PM IST
      New Delhi : Ajay Piramal-led Piramal Enterprises has entered into an agreement to acquire four brands from Pfizer for a consideration of Rs 110...
      Regeneron CEO calls ICER critique of new cholesterol therapy non scientific

      Regeneron CEO calls ICER critique of new cholesterol therapy non scientific

      savita thakur thakur15 May 2016 9:11 AM IST
      New York : Regeneron Pharmaceuticals Chief Executive Leonard Schleifer on Thursday took aim at an influential drug pricing watchdog, saying a critique...
      Talwalkars Better Value Fitness to Raise upto Rs 125 cr Via NCDs

      Talwalkars Better Value Fitness to Raise upto Rs 125 cr Via NCDs

      savita thakur thakur15 May 2016 9:09 AM IST
      New Delhi : Fitness chain Talwalkars Better Value Fitness looks to raise up to Rs 125 crore through non convertible debentures (NCDs) to fund its...
      USFDA nod to Aurobindo Pharmas generic Zolmitriptantab for migraine

      USFDA nod to Aurobindo Pharma's generic Zolmitriptantab for migraine

      savita thakur thakur14 May 2016 2:39 PM IST
      New Delhi : Aurobindo Pharma has received approval from the US health regulator to sell generic Zolmitriptan tablets, a drug used to treat migraine,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok